First-line biological versus conventional synthetic disease-modifying antirheumatic drug therapy in adult-onset Still's disease: a multicentre, retrospective, propensity weighted cohort study.
The Lancet. Rheumatology
View this publicationThe Lancet. Rheumatology
View this publicationOxidative medicine and cellular longevity
View this publicationCurrent opinion in neurobiology
View this publicationPloS one
View this publicationCell metabolism
View this publicationStroke
View this publicationMolecular systems biology
View this publicationJournal of patient-reported outcomes
View this publicationDie Anaesthesiologie
View this publicationExperimental eye research
View this publication